New class of type 2 diabetes drug associated with rare, life-threatening outcome
A new class of drugs, known as SGLT2 inhibitors, is increasingly being prescribed for the treatment of type 2 diabetes, but may increase the risk of rare but serious complication known as diabetic ketoacidosis. In a new study ...
Jun 7, 2017
0
7